New Safety Worries Spark FDA Scrutiny Of Metal Hip Implants

Law360, New York (March 29, 2012, 3:13 PM EDT) -- The U.S. Food and Drug Administration will seek scientific and clinical advice as it considers more rigorous testing and review requirements for metal-on-metal hip replacement systems, the agency announced Thursday.

Recent data noting an increased failure rate for certain metal-on-metal hip systems have added to existing safety concerns, the FDA said, leading the agency to call a two-day expert advisory panel meeting for June 27-28 to discuss failure rates and modes, local and systematic complications, and patient risk factors, among other topics. 

“We are asking outside...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.